Use of oxandrolone in the treatment of burns and other wounds

Details Use of oxandrolone in the treatment of burns and other wounds Use of oxandrolone in the treatment of burns and other wounds

2004-03-12

2011-11-08

Anderson, James (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S453000

Reexamination Certificate

active

08053425

ABSTRACT:
The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient.

REFERENCES:
patent: 3128283 (1964-04-01), Pappo et al.
patent: 4112123 (1978-09-01), Roberts
patent: 4456596 (1984-06-01), Schafer
patent: 5021404 (1991-06-01), Folkman et al.
patent: 5096916 (1992-03-01), Skupin
patent: 5340586 (1994-08-01), Pike
patent: 5434146 (1995-07-01), Labrie et al.
patent: 5461030 (1995-10-01), Lindenbaum
patent: 5532230 (1996-07-01), Daynes et al.
patent: 5726146 (1998-03-01), Almada et al.
patent: 5872147 (1999-02-01), Bowen
patent: 5922701 (1999-07-01), Araneo
patent: 6011023 (2000-01-01), Clark et al.
patent: 6090799 (2000-07-01), Berger
patent: 6576659 (2003-06-01), Fishbein
patent: 6670351 (2003-12-01), Berger
patent: 6828313 (2004-12-01), Fishbein
patent: 2003/0049716 (2003-03-01), Barton et al.
patent: 2004/0235940 (2004-11-01), Fishbein
patent: 0222385 (1993-02-01), None
Demling, R.H. “Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat.” Wound Repair and Regeneration (Mar.-Apr. 2000): pp. 97-102.
Demling, R.H.. “Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury.” (1999) Burns 25: pp. 215-221.
Demling, R.H. and DeSanti, L. “Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns.” (1997) The Journal of trauma: Injury, Infection, and Critical Case 43(1): pp. 47-51.
Deming. R.H. “Use of anticatabolic agents for burns.” (1996) Current Opinions in Critical Care, vol. 2: pp. 482-491.
STN Registry Search Results for Synonymous Chemical Names of Oxandrolone (2 pages).
Demling, Robert H., “Oxandrolone Induced Lean Mass Gain During Recovery From Severe Burns Is Maintained After Discontinuation of the Anabolic Steroid,” Burns, vol. 29, pp. 793-797 (2003).
Herndon et al., Treatment of Burns, Curr. Probl. Surg., 1987, vol. 2, pp. 347-397.
Wolfe R.R., Nutrition and Metabolism in Burns, In Chernow B. and shoemaker W.C., eds., Critical Care, State of the Art, Fullerton, California, Society of Critical Care Medicine, 1986, vol. 7, pp. 19-61, (Chernow & Shoemaker, eds.).
Fox et al. (1962), J. Clin. Endocrinol. Metab. 22: 921-924.
Solymoss et al. Toxicol. Appl. Pharmacol., 18 (3), 586-92 Abstract Only.
U.S. Appl. No. 10/011,377, filed Oct. 22, 2001, with the claims as allowed. (Exhibit 2).
U.S. Appl. No. 10/052,961, filed Jan. 18, 2002, with the claims as pending. (Exhibit 3).
Karim et al. (1973), Clin. Pharmacol. Ther. 14:862-869.
Roubeoff et al. (1991), Nutrition Reviews 49(6):163-175.
Kopera H. (1985), Acta Endocrinologica, Supplementum 271: 11-18.
Garlick et al. In Ballier's Clinical Gastroenterology, Burns ed., vol. 2, No. 4, 1988, pp. 915-940 (Burns, ed.).
Haupt et al. (1984), The American Journal of Sports Medicine 12(6) : 469-484.
Wilson, J. D. in Goodman and Gilman's, The pharmacological Basis of Therapeutics, Eight Edition, Pergamon Press, 1990, pp. 1413-1430.
Demling et al., Current Opinion in Critical Care (1996) 2:482-491.
Kowalewski et al., Acta Endocrinologica (1970) 64: 541-547 (1974).
Marmo et al., Gazzetta Medica Italiana (in Italian) (1974) 133:47-57—13a English translation.
Albanese et al., Nutrition Reports International (1970)1(4):213-242.
O'Shea et al., Nutrition Report International(1970)2(6):351-362.
Selye, Exp. Med. Surg., 28(2), 169-78 Abstract Only.
May 14, 1999 letter from the Department of Health and Human Services, Center for Drug Evaluation and Research, Rockville, Maryland, providing a “Copy of All Disclosable Approval Information for the Product Oxandrin, Manufactured by Biotechnology General,” 30 pages.
Albanese, A.A. et al. (1962) “Nutritional and Metabolic Effects of Some Newer Steroids, Oxandrolone and Trimacinolone”New York State J. Med.62:1607-1613.
Berkowitz, D. (Apr. 25, 1962) Clinical Investigator's Report.
Chicago Tribune (Sep. 20, 1991), North Sports Final Edition, Business Section, p. 1.
Demling, et al. (1997) “Oxandrolone, An Anabolic Steroid, Significantly Increases the Rate of Weight Gain in the Recovery Phase After Major Burns”J. Trauma43(1):47-51.
Demling, et al. (1998) “Closure of the ‘Non-Healing Wound’ Corresponds with Correction of Weight Loss Using the Anabolic Agent Oxandrolone,”Ostomy/Wound Management44(10):58-68.
Demling, et al. (1999) “Comparison of the Anabolic Effects and Complications of Human Growth Hormone and the Testosterone Analog, Oxandrolone, After Severe Burn Injury,”Burns25:215-221.
Demling, et al. (2000) “Oxandrolone, an Anabolic Steriod, Enhances the Healing of a Cutaneous Wound in the Rat,”Wound Repair Regen8(2):97-102.
Demling, et al. (2001) “The Rate of Restoration of Body Weight After Burn Injury, Using the Anabolic Agent Oxandrolone, is not Age Dependent”Burns17:46-51.
Demling, et al. (2001) “The Anabolic Steroid, Oxandrolone, Reverses the Wound Healing Impairment in Corticosteroid-Dependent Burn and Wound Patients,”Wounds13(5):203-207.
DeSanti, et al. (1998) “Development of a Burn Rehabilitatin Unit: Impact on Burn Center Length of Stay and Functional Outcome,”Journal of Burn Care&Rehabilitation19(5):414-419.
Ehrlich, et al. (1969) “The Effects of Cortisone and Anabolic Steroids on the Tensile Strength of Healing Wounds,”Ann Surg.170(2):203-206.
Eisenberg (1966) 65, Chemical Abstracts:40387.
Eisenberg (1966) “Effects of Androgens, EStrogens and Corticoids on Strontium Kinetics in Man,”J. Clin. Endocr.26:566-572.
Draft of G.D. Searle & Co. (1962), Physicians' Product Brochure No. 43, “ANAVAR® Brand of Oxandrolone, For Protein Tissue Building and Anabolism,” 16 pg. with a 5 page insert.
FDA approved Physician's Product Brochure No. 43 for ANAVAR® Brand of Oxandrolone, including Package Insert, G.D. Searle (1964).
Ferraresi (1996) “Clinical Profile of Oxandrin,” BTG Pharmaceuticals.
Gold, E.M. (May 31, 1962) Clinical Investigator's Report.
Grant (1980) “Patient Selection,” inHandbook of Total Parenteral Nutrition, Saunders, pp. 7-46.
Hausmann, et al. (1990) “Anabolic Steroids in Polytrauma Patients. Influence on Renal Nitrogen and Amino Acid Losses: A Double Blind Study,”J. Parent. Enteral. Nutr.14(2):111-114.
Helfman, et al. (1995) “Stanozolol as a Novel Therapeutic Agent in Dermatology,”J. of the American Acad. of Dermatology33(2):254-258.
Heller, C.G. (Jun. 20, 1962) Clinical Investigator's Report.
Jekot et al. (1993) “Treating HIV/AIDS Patients with Anabolic Steroids,”AIDS Patient Care68-74.
Kasler, M.H. Clinical Investigator's Report, (Mar. 16, 1962).
Koehler et al. (1998) “Achieving Healing of Non-Healing Pressure Ulcers,” WOCN 30thAnnual Conference, p. 37.
Kotler (1996) “Dilemmas in the Treatment of Weight Loss” BTG Pharmaceuticals pp. 1-7.
Leevy, C.M. (Aug. 24, 1961) Clinical Investigator's Report.
Levien et al. (1994) “Reviews of Trimetrexate and Oxandrolone,” ;Hospital Pharmacy29(7):696-702, 705-708.
Martindale (1982)The Extra Pharmacopoeia 28thedition, The Pharmaceutical Press, London, Reynolds and Prasad Eds., p. 1430.
Mensch, M., Clinical Investigator's Report, Aug. 23, 1962.
Metcalf, W., Clinical Investigator's Report, Jul. 14, 1961.
Paulsen, C.A., Clinical Investigator's R

Affiliated with

Also associated with

Rating

Use of oxandrolone in the treatment of burns and other wounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of oxandrolone in the treatment of burns and other wounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of oxandrolone in the treatment of burns and other wounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4284686